病例信息患者吕*，男，33岁，主因“发现血肌酐升高3月，周身水肿半月”入院。现病史：患者入院前3月因“原发性血小板减少症”复诊时发现血肌酐升高，为106μmol/L，当时无尿量及尿色改变，无下肢水肿，无恶心、呕吐，无胸闷憋、气，无脱发、光过敏，无皮疹、关节肿痛等，患者未行诊治。入院前半月患者无明显诱因出现周身水 ...

Living with this chronic platelet disorder is linked to stress, anxiety, and depression, but these tips can help.

Recently however, reports of thrombosis and thrombocytopenia following vaccination with the ChAdOx1 nCoV-19 vaccine have emerged. This paper aims to review the available literature and guidelines ...

One of the most common causes of thrombocytopenia, immune thrombocytopenic purpura (ITP), can cause a severe reduction in the circulating platelet count, with a subset of affected individuals not ...

These findings suggest that AIC patients with Evans syndrome or AIHA should be evaluated for PID, and lymphocyte subsets and immune globulins can serve as a rapid screen for underlying PID.

The 42-year-old TV presenter suffers from Immune thrombocytopenic purpura (ITP), a disorder that results in low platelet levels, often causing excessive bruising. Despite the effects of the ...

The Korea Food and Drug Administration announced on the 20th that it has approved the adult immune thrombocytopenia treatment 'Tavalisse' (ingredient name fostamatinib), developed by the American ...

In Immune Thrombocytopenia (ITP), IgG targets glycoproteins on the surface of platelets leading to platelet depletion, disruption of the clotting cascade and dangerous internal bleeding.

JW Pharmaceutical announced on the 21st that its immune thrombocytopenia (ITP) treatment 'Tavalisse 100·150mg (active ingredient fostamatinib)' received product approval from the Ministry of Food ...